Disease/Infection News

RSS

Research finds 50 million people vaccinated against zoonotic brain infection

Research at the University of Liverpool has supported the vaccination of more than 50 million people against a zoonotic brain infection that affects thousands of children across Asia every year.

7 Oct 2009

Mexican Health Minister to discuss preparations and responses to H1N1 influenza

Jose Angel Cordova Villalobos, Secretary of Health, United States of Mexico, discussed preparations and responses to the H1N1 influenza during a visit to Washington D.C.

7 Oct 2009

Parents should watch out for flu warning signs, says Minnesota physicians

Minnesota's physicians are urging parents to watch for the warning signs that their child is having a severe case of H1N1 and to seek out the H1N1 vaccine for their child when it becomes available.

7 Oct 2009

Research to explore diagnosis and treatment of rare diseases

The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.

7 Oct 2009

Reuters examines health effects of climate change in Africa

Reuters examines how floods, droughts and rising temperatures, thought to be caused by climate change, are compromising African farm lands and leading to health problems for already vulnerable populations - a topic discussed at the "first pan-African climate hearings."

7 Oct 2009

USAID grants over $10.5 million for fight against malaria

The U.S. government, through the U.S. Agency for International Development (USAID), announced over $10.5 million in grants to seven organizations working in six countries in Africa to extend malaria prevention and control activities in communities most affected by the disease, particularly children under age 5 and pregnant women.

7 Oct 2009

New study leads to the development of first prophylactic treatment for leishmania

Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.

7 Oct 2009

Opinion piece responds to 'skeptics' of development aid

After a recent trip to Africa, "to see firsthand the region's fight against malaria," Tachi Yamada, the president of the Global Health Program at the Bill & Melinda Gates Foundation, writes in a CNN opinion piece that a visit to a pediatric hospital ward in Zanzibar that did not have "a single patient" was the "single most memorable image of the trip."

7 Oct 2009

New cases of H1N1 worldwide up 24,000 in two weeks

The number of H1N1 (swine flu) cases reported in WHO regions worldwide has grown by at least 24,000 in two weeks to cross the 340,000 mark since the virus was first detected in mid-April, the CDC reported Monday, according to Agence France-Presse.

7 Oct 2009

Measures taken by Memorial Blood Centers to stay prepared for the spread of H1N1 virus

Memorial Blood Centers today outlined steps the organization is taking to stay prepared for the spread of the H1N1 virus and to ensure a safe experience for blood donors and an ample blood supply for our communities.

7 Oct 2009

Get vaccinated against both H1N1 flu and the seasonal flu, advises Chief Nurse of the American Red Cross

With the first doses of the H1N1 (swine) flu vaccine being shipped and seasonal flu shots underway, people should be getting vaccinations when they can for these flu viruses, said Sharon Stanley, Chief Nurse of the American Red Cross.

7 Oct 2009

PSI-879 nominated as second development candidate for treating HCV infection

Pharmasset, Inc. announced today the nomination of PSI-352879 (PSI-879) as a second development candidate from two series of purine analogs for the treatment of chronic hepatitis C virus (HCV) infection.

7 Oct 2009

AARP recommends older adults to get seasonal flu vaccination this year

With the thermometer dropping and the onset of flu season upon us, AARP is reaching out to their membership and the public to encourage them to get a seasonal flu vaccine this year.

7 Oct 2009

Phase 2 clinical study results of TOPICA's luliconazole for athlete's foot announced

TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced positive results from its Phase 2 clinical study evaluating luliconazole, one of the most potent and broad spectrum topical antifungal agents, in patients with tinea pedis (athlete's foot). The study was designed to assess the effectiveness of 1% luliconazole cream applied once daily for 14 days compared with once daily for 28 days.

6 Oct 2009

Hepatitis B Foundation calls for consistent monitoring and referral of HBV infected children

An expert panel of nationally recognized pediatric liver specialists convened by the Hepatitis B Foundation is calling for more consistent monitoring and referral of children chronically infected with the hepatitis B virus (HBV). The panel's recommendations for pediatricians and other primary care practitioners stress the need for routine monitoring of children with chronic HBV infections, and timely consultation with a pediatric liver specialist.

6 Oct 2009

Researchers to investigate Buruli ulcer outbreaks

Knowing what causes a disease may not make it easier to control and contain infection, but understanding how humans become infected and where the pathogens live may improve control.

6 Oct 2009

HIV prevalence high among African Americans

HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.

6 Oct 2009

Emergency preparedness and business continuity planning to prevent and manage H1N1 virus

This fall the CDC estimates that upwards of 50 percent of Americans could come down with the H1N1 virus, killing as many as 1.2 million people. Additionally, there are estimates that many companies will experience between 30-50 percent absenteeism due to employee illness.

6 Oct 2009

Key defence mechanism used by the immune system against Listeria identified

A team of University of British Columbia microbiologists has identified a key defence mechanism used by the immune system against Listeria with strong implications for the future development of vaccines.

6 Oct 2009

NIAID's grant to VBI for biomedical research on infectious diseases

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year, $27,670,448 contract to the CyberInfrastructure Group (CIG) of the Virginia Bioinformatics Institute (VBI) at Virginia Tech to support the biomedical research community's work on infectious diseases.

6 Oct 2009